Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

Background: Ceftazidime-avibactam (CZA) is the preferred treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to investigate the prognostic factors of 28-day mortality and 14-day clinical failure in patients treated with CZA for CZA-susceptible CRKP...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yi-Tsung Lin, Shih-Neng Lin, Chien Chuang, Szu-Yu Liu, Yu-Chien Ho, Chih-Han Juan, Hsiang-Ling Ho, Sheng-Hua Chou
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-09-01
Serie:	Journal of Infection and Public Health
Soggetti:	Ceftazidime-avibactam Bacteremia Mortality Risk factors
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1876034125001856
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!